Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ERA Biotech logo — company profile

ERA Biotech

Founded 2002 Series B Total: $12.88M Biopharma, Biotechnology +1

General Information

Company Name ERA Biotech
Founded Year 2002
Industries Biopharma, Biotechnology, Manufacturing
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with ERA Biotech. To contact ERA Biotech, visit erabiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ERA Biotech compare?

A PDF of ERA Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ERA Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ERA Biotech

ERA Biotech is a biotech company that focuses on enhancing and implementing advanced cell-based biomanufacturing technologies. Founded in 2002, the company operates in the industries of Biopharma, Biotechnology, and Manufacturing. ERA Biotech's Zera® and StorPro® tools are designed to boost performance in standard eukaryotic culture systems used for the production of protein drugs, enzymes, and other biological products.

The most recent investment in ERA Biotech was a Series B round, which amounted to $5.30M, and took place on 16th September 2009. The investment was made by Omnes Capital, Axia Capital Corp, and BCN Ventures.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $5.30M 3
Omnes Capital
Omnes Capital, BCN Ventures +1
16 Sep 2009
Venture Round $6.18M 6
Uninvest
Uninvest, Invertec +4
03 Jun 2008
Convertible Note €1.40M 1
Invertec
14 Dec 2006

ERA Biotech Alternatives & Competitors

ERA Biotech vs
LFB Biomanufacturing
LFB Biomanufacturing France

Your CDMO partner for antibodies and recombinant proteins

153 employees
Biotechnology, Manufacturing
ERA Biotech vs
神州细胞工程有限公司
神州细胞工程有限公司

Pioneering accessible and affordable biological medicines through advanced protein and antibody tech...

Series A
91 employees
Biotechnology, Health Care
ERA Biotech vs
Ventria Bioscience
Ventria Bioscience

Ventria Bioscience is a privately held biopharmaceutical company that leverages its proprietary Expr...

Grant
Biotechnology, Health Care

FAQ About ERA Biotech

ERA Biotech enhances and implements advanced cell-based biomanufacturing technologies. Our Zera® and StorPro® tools boost performance in most standard eukaryotic culture systems used today for the production of protein drugs, enzymes, and other biological products.
ERA Biotech was founded in 2002.
ERA Biotech operates in Biopharma, Biotechnology and Manufacturing.
ERA Biotech has completed 3 funding rounds, raising a total of $12.88M. The latest funding stage is Series B.
Top alternatives and competitors to ERA Biotech include LFB Biomanufacturing, 神州细胞工程有限公司, Ventria Bioscience, T&L Biotechnology, Arzeda. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ERA Biotech and LFB Biomanufacturing are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ERA Biotech, https://bouncewatch.com/company/era-biotech, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes